This issue starts volume 100 of the International Journal of Cancer. It marks the success story of a periodical devoted from the beginning to representing an international forum for cancer research. The journal receives a large flow of submissions from all parts of the world, and the Editorial Board puts considerable effort into selecting papers of high quality while offering a broad scope for innovative work in established and newly arising fields of cancer research. In spite of the high competition with other journals, the International Journal of Cancer has maintained and even increased its readership and is proud to represent a flagship of publications of the UICC.
Volume 100 also provides a good opportunity to thank all those who have contributed to the success of this journal. In the early phase Professors Lauri Saxe ยดn and Eero Saksela in Helsinki launched IJC and laid the foundation for its international acceptance. Subsequently, Professor Nicholas Odartchenko in Lausanne contributed effectively to further expand it. In January 2000 the Editorial Office moved to Heidelberg. Since then a number of changes have been introduced to modernize the shape and style of the journal and to further streamline the scientific content. Very recently, a new column "Spotlight" was added to highlight the editors' choices of particularly interesting papers being published in the respective issue.
During the past 2 1 โ2 years a new editorial team has been composed, too. I am grateful for the enormous help provided by the Associate Editors Helmut Bartsch, Norbert Fusenig, Peter Krammer, Peter Lichter, Anthony Miller, and David Sidransky. Their assistance is of particular importance for the journal. On July 1, 2002, Volker Diehl will be joining us and offering his particular expertise to our board. We are looking forward to his contribution. My gratitude also includes the devoted team in the Editorial Office, initially headed by Leslie Thomas, since February this year by Sherryl Sundell. Members of the Editorial Board have frequently been asked to act as referees and have been extremely helpful. It would have been impossible, however, to fairly analyze the large number of submissions without the aid of additional reviewers. This issue lists those who have helped us since January 2000 in assessing the quality of submitted manuscripts. We gratefully acknowledge their constant support.
The International Journal of Cancer contributes to the aims of the UICC and will continue to do so in the future. At the same time we are grateful for the support we have been given by the UICC office in Geneva, headed by Isabel Mortara. Last but not least, we would like to express our gratitude to the Publisher, Wiley, New York, for their always helpful advice and constructive cooperation and for the care they take in producing the journal.
The Editors are convinced that the International Journal of Cancer will continue to play an important role in the world-wide dissemination of discoveries in cancer research and trust that it will thrive as well, or even better, for at least the next 100 volumes to come.